| 6.6 |
19.7 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 5.9 |
17.7 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 5.9 |
17.6 |
GO:0035934 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 5.4 |
16.2 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 4.9 |
4.9 |
GO:0051938 |
L-glutamate import(GO:0051938) L-glutamate import across plasma membrane(GO:0098712) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 4.8 |
24.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 4.7 |
28.2 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 4.7 |
18.7 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 4.6 |
13.8 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 4.3 |
12.9 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 4.2 |
20.8 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 4.1 |
12.3 |
GO:0002030 |
inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
| 4.1 |
4.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 4.0 |
4.0 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 4.0 |
19.9 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 3.9 |
3.9 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 3.9 |
3.9 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 3.8 |
15.4 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 3.8 |
7.6 |
GO:0038042 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 3.7 |
11.2 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 3.7 |
11.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 3.5 |
14.0 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 3.4 |
17.2 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 3.4 |
10.1 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 3.4 |
16.8 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 3.3 |
13.4 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 3.3 |
10.0 |
GO:0071336 |
regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 3.3 |
13.2 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) |
| 3.2 |
9.6 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 3.1 |
9.3 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 3.1 |
9.2 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 3.0 |
15.2 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 3.0 |
26.7 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 3.0 |
20.7 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 2.9 |
2.9 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 2.9 |
8.6 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 2.8 |
8.5 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 2.8 |
11.1 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 2.8 |
8.3 |
GO:1903538 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 2.8 |
8.3 |
GO:0051940 |
regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 2.7 |
8.2 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 2.7 |
2.7 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 2.7 |
16.3 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 2.7 |
10.8 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 2.7 |
8.0 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 2.7 |
8.0 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 2.6 |
5.3 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 2.5 |
5.0 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 2.5 |
10.0 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 2.5 |
2.5 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 2.5 |
9.9 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 2.5 |
12.3 |
GO:1903598 |
angiotensin-activated signaling pathway involved in heart process(GO:0086098) negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) positive regulation of gap junction assembly(GO:1903598) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 2.4 |
9.8 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 2.4 |
21.8 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 2.4 |
9.7 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 2.4 |
2.4 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 2.4 |
19.1 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 2.4 |
14.3 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.4 |
7.1 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 2.3 |
21.1 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 2.3 |
11.7 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 2.3 |
2.3 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 2.3 |
13.8 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 2.3 |
32.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 2.3 |
2.3 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 2.3 |
9.2 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 2.3 |
2.3 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 2.3 |
2.3 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 2.3 |
11.3 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 2.2 |
2.2 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 2.2 |
9.0 |
GO:0021586 |
pons maturation(GO:0021586) |
| 2.2 |
24.6 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 2.2 |
2.2 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 2.2 |
6.6 |
GO:1902218 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
| 2.2 |
2.2 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 2.2 |
6.6 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 2.2 |
6.5 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 2.2 |
15.2 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 2.2 |
2.2 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 2.2 |
4.3 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 2.1 |
8.6 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 2.1 |
6.4 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 2.1 |
6.4 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 2.1 |
6.4 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 2.1 |
8.5 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 2.1 |
10.5 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 2.1 |
25.2 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 2.1 |
10.5 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 2.1 |
14.6 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 2.1 |
18.6 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 2.1 |
4.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 2.1 |
8.2 |
GO:1901166 |
neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 2.0 |
2.0 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 2.0 |
6.1 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 2.0 |
6.1 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 2.0 |
10.2 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 2.0 |
18.2 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 2.0 |
4.0 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 2.0 |
4.0 |
GO:0003057 |
regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 2.0 |
2.0 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 2.0 |
2.0 |
GO:1902474 |
regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 2.0 |
4.0 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 2.0 |
4.0 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 2.0 |
6.0 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 2.0 |
2.0 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 2.0 |
9.8 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 2.0 |
5.9 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 2.0 |
5.9 |
GO:0099548 |
trans-synaptic signaling by nitric oxide(GO:0099548) |
| 2.0 |
11.7 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 2.0 |
2.0 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 1.9 |
1.9 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 1.9 |
3.9 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 1.9 |
5.8 |
GO:1905072 |
cardiac jelly development(GO:1905072) |
| 1.9 |
15.5 |
GO:0014824 |
artery smooth muscle contraction(GO:0014824) |
| 1.9 |
3.9 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.9 |
5.8 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 1.9 |
7.7 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.9 |
1.9 |
GO:0035793 |
cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 1.9 |
11.5 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 1.9 |
19.0 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 1.9 |
5.7 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 1.9 |
9.5 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 1.9 |
7.6 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 1.9 |
3.8 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 1.9 |
3.8 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 1.9 |
7.6 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 1.9 |
5.6 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 1.9 |
1.9 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 1.9 |
1.9 |
GO:0019062 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 1.9 |
7.4 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 1.8 |
16.6 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 1.8 |
7.4 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 1.8 |
3.7 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.8 |
14.6 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 1.8 |
9.1 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 1.8 |
3.6 |
GO:0061744 |
motor behavior(GO:0061744) |
| 1.8 |
1.8 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 1.8 |
3.6 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 1.8 |
21.6 |
GO:0002323 |
natural killer cell activation involved in immune response(GO:0002323) |
| 1.8 |
1.8 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.8 |
5.4 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 1.8 |
7.2 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.8 |
7.1 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 1.8 |
1.8 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 1.8 |
5.3 |
GO:1905169 |
protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 1.8 |
1.8 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 1.8 |
12.4 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.8 |
3.5 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) |
| 1.8 |
1.8 |
GO:1903294 |
regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 1.8 |
3.5 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 1.7 |
12.2 |
GO:1903874 |
ferrous iron transmembrane transport(GO:1903874) |
| 1.7 |
5.2 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 1.7 |
10.4 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.7 |
8.7 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 1.7 |
10.4 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 1.7 |
13.7 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 1.7 |
5.1 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.7 |
1.7 |
GO:0099552 |
trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 1.7 |
1.7 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 1.7 |
1.7 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 1.7 |
5.1 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.7 |
5.0 |
GO:0015747 |
urate transport(GO:0015747) |
| 1.7 |
11.7 |
GO:0002283 |
neutrophil activation involved in immune response(GO:0002283) |
| 1.7 |
8.4 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.7 |
18.4 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 1.7 |
5.0 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 1.7 |
6.6 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 1.7 |
6.6 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 1.6 |
1.6 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 1.6 |
1.6 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.6 |
6.5 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 1.6 |
14.6 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 1.6 |
1.6 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 1.6 |
4.9 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 1.6 |
4.8 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 1.6 |
1.6 |
GO:0051797 |
regulation of hair follicle development(GO:0051797) |
| 1.6 |
9.6 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.6 |
8.0 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 1.6 |
1.6 |
GO:0007619 |
courtship behavior(GO:0007619) |
| 1.6 |
6.3 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 1.6 |
6.3 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 1.6 |
4.7 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 1.6 |
1.6 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 1.6 |
4.7 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.6 |
4.7 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.6 |
3.1 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 1.6 |
4.7 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 1.6 |
3.1 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 1.5 |
1.5 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.5 |
3.1 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 1.5 |
4.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.5 |
6.2 |
GO:0042822 |
pyridoxal phosphate metabolic process(GO:0042822) |
| 1.5 |
4.6 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 1.5 |
4.6 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 1.5 |
7.7 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 1.5 |
4.6 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 1.5 |
4.6 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 1.5 |
7.6 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 1.5 |
4.5 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 1.5 |
9.0 |
GO:0032439 |
endosome localization(GO:0032439) |
| 1.5 |
7.5 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 1.5 |
4.5 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 1.5 |
1.5 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 1.5 |
4.5 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.5 |
5.9 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 1.5 |
4.4 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 1.5 |
4.4 |
GO:0030070 |
insulin processing(GO:0030070) |
| 1.5 |
11.8 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.5 |
5.9 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 1.5 |
4.4 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 1.5 |
1.5 |
GO:0030431 |
sleep(GO:0030431) |
| 1.5 |
10.2 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 1.5 |
2.9 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 1.5 |
4.4 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 1.5 |
10.2 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 1.5 |
2.9 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 1.5 |
4.4 |
GO:0061623 |
glycolytic process from galactose(GO:0061623) |
| 1.5 |
4.4 |
GO:0072737 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 1.4 |
1.4 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 1.4 |
4.3 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.4 |
5.8 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 1.4 |
4.3 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 1.4 |
5.7 |
GO:0001821 |
histamine secretion(GO:0001821) histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 1.4 |
4.3 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.4 |
2.9 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 1.4 |
5.7 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 1.4 |
4.3 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 1.4 |
7.1 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 1.4 |
14.1 |
GO:0032341 |
mineralocorticoid metabolic process(GO:0008212) aldosterone metabolic process(GO:0032341) |
| 1.4 |
1.4 |
GO:0060003 |
copper ion export(GO:0060003) |
| 1.4 |
4.2 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 1.4 |
5.6 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 1.4 |
1.4 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 1.4 |
37.4 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 1.4 |
5.5 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.4 |
1.4 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.4 |
6.8 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 1.4 |
2.7 |
GO:0030578 |
PML body organization(GO:0030578) |
| 1.4 |
5.4 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 1.4 |
5.4 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 1.4 |
36.7 |
GO:0090662 |
ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 1.4 |
2.7 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 1.4 |
1.4 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 1.3 |
4.0 |
GO:0010248 |
B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 1.3 |
2.7 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 1.3 |
4.0 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 1.3 |
6.7 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 1.3 |
1.3 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 1.3 |
2.7 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 1.3 |
4.0 |
GO:0048866 |
stem cell fate specification(GO:0048866) |
| 1.3 |
8.0 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 1.3 |
1.3 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) |
| 1.3 |
1.3 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 1.3 |
15.9 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 1.3 |
23.8 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 1.3 |
2.6 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 1.3 |
11.9 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 1.3 |
2.6 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.3 |
4.0 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 1.3 |
7.9 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 1.3 |
1.3 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) |
| 1.3 |
3.9 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 1.3 |
3.9 |
GO:0061075 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 1.3 |
18.2 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 1.3 |
9.1 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 1.3 |
22.1 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 1.3 |
3.9 |
GO:0030974 |
thiamine pyrophosphate transport(GO:0030974) |
| 1.3 |
2.6 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 1.3 |
10.3 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 1.3 |
3.9 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.3 |
2.6 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.3 |
14.2 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 1.3 |
3.9 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 1.3 |
6.4 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 1.3 |
3.8 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 1.3 |
6.4 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 1.3 |
3.8 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 1.3 |
5.1 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 1.3 |
20.5 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.3 |
3.8 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 1.3 |
1.3 |
GO:0045575 |
basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 1.3 |
8.9 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 1.3 |
6.4 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 1.3 |
3.8 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.3 |
14.0 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 1.3 |
2.5 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 1.3 |
1.3 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 1.3 |
3.8 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 1.3 |
6.3 |
GO:0099628 |
receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
| 1.3 |
1.3 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 1.3 |
1.3 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 1.3 |
2.5 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 1.3 |
5.0 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 1.3 |
2.5 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 1.3 |
3.8 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 1.3 |
23.8 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 1.3 |
13.8 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 1.2 |
1.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 1.2 |
3.7 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 1.2 |
1.2 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 1.2 |
3.7 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 1.2 |
1.2 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.2 |
2.5 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 1.2 |
6.2 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 1.2 |
4.9 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 1.2 |
1.2 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 1.2 |
7.3 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.2 |
2.4 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 1.2 |
4.8 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 1.2 |
1.2 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 1.2 |
1.2 |
GO:1902869 |
regulation of amacrine cell differentiation(GO:1902869) |
| 1.2 |
1.2 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 1.2 |
5.9 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 1.2 |
2.4 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 1.2 |
3.5 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.2 |
1.2 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 1.2 |
3.5 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 1.2 |
8.3 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 1.2 |
1.2 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 1.2 |
1.2 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 1.2 |
3.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.2 |
7.0 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 1.2 |
1.2 |
GO:0048289 |
isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
| 1.2 |
1.2 |
GO:1903147 |
negative regulation of mitophagy(GO:1903147) |
| 1.2 |
2.3 |
GO:0001803 |
type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 1.2 |
2.3 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 1.2 |
31.5 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 1.2 |
4.7 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 1.2 |
4.7 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 1.2 |
2.3 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 1.2 |
3.5 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 1.2 |
4.6 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 1.1 |
1.1 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 1.1 |
4.6 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 1.1 |
6.9 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 1.1 |
2.3 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 1.1 |
2.3 |
GO:0006929 |
substrate-dependent cell migration(GO:0006929) |
| 1.1 |
1.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 1.1 |
3.4 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.1 |
6.8 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.1 |
3.4 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) |
| 1.1 |
3.4 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 1.1 |
1.1 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 1.1 |
1.1 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 1.1 |
2.2 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 1.1 |
11.2 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 1.1 |
15.7 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 1.1 |
3.4 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 1.1 |
12.3 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 1.1 |
4.5 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 1.1 |
2.2 |
GO:0019081 |
viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
| 1.1 |
4.4 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 1.1 |
5.5 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 1.1 |
14.4 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 1.1 |
3.3 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 1.1 |
3.3 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 1.1 |
3.3 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.1 |
7.7 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 1.1 |
2.2 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.1 |
1.1 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 1.1 |
2.2 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 1.1 |
7.6 |
GO:0015862 |
uridine transport(GO:0015862) |
| 1.1 |
5.5 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.1 |
2.2 |
GO:0021892 |
cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
| 1.1 |
4.3 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 1.1 |
7.6 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 1.1 |
1.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 1.1 |
2.1 |
GO:0071236 |
cellular response to antibiotic(GO:0071236) |
| 1.1 |
1.1 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 1.1 |
6.4 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 1.1 |
1.1 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 1.1 |
2.1 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.1 |
1.1 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 1.1 |
5.3 |
GO:0080184 |
response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 1.0 |
5.2 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 1.0 |
10.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 1.0 |
3.1 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 1.0 |
2.1 |
GO:0072199 |
mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
| 1.0 |
13.5 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 1.0 |
1.0 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 1.0 |
9.3 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 1.0 |
7.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.0 |
9.3 |
GO:0015816 |
glycine transport(GO:0015816) |
| 1.0 |
4.1 |
GO:0046709 |
IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 1.0 |
1.0 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 1.0 |
6.1 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 1.0 |
3.1 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 1.0 |
3.1 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 1.0 |
11.2 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 1.0 |
1.0 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 1.0 |
20.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 1.0 |
3.1 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 1.0 |
2.0 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 1.0 |
7.1 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 1.0 |
8.1 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 1.0 |
3.0 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 1.0 |
2.0 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.0 |
1.0 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 1.0 |
2.0 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 1.0 |
4.0 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 1.0 |
4.0 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.0 |
5.0 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 1.0 |
4.0 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 1.0 |
2.0 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 1.0 |
2.0 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 1.0 |
3.0 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 1.0 |
3.9 |
GO:0009227 |
nucleotide-sugar catabolic process(GO:0009227) |
| 1.0 |
2.9 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 1.0 |
9.8 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 1.0 |
5.9 |
GO:0003253 |
cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
| 1.0 |
2.9 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 1.0 |
1.0 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 1.0 |
3.9 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 1.0 |
1.9 |
GO:0050904 |
diapedesis(GO:0050904) |
| 1.0 |
1.0 |
GO:1900125 |
regulation of hyaluronan biosynthetic process(GO:1900125) |
| 1.0 |
9.6 |
GO:0098969 |
neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 1.0 |
5.8 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 1.0 |
10.6 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 1.0 |
1.0 |
GO:0009415 |
response to water(GO:0009415) response to hydrostatic pressure(GO:0051599) |
| 1.0 |
12.5 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 1.0 |
1.0 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 1.0 |
3.8 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.0 |
11.5 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 1.0 |
15.3 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 1.0 |
11.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.0 |
1.0 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.9 |
2.8 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.9 |
4.7 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.9 |
5.7 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.9 |
0.9 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.9 |
1.9 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.9 |
4.7 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.9 |
0.9 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.9 |
8.4 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.9 |
0.9 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.9 |
5.6 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.9 |
3.7 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.9 |
0.9 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.9 |
3.7 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.9 |
3.7 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.9 |
7.4 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.9 |
3.7 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.9 |
0.9 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.9 |
5.5 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.9 |
6.4 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.9 |
11.0 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.9 |
3.7 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.9 |
3.7 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.9 |
9.1 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.9 |
1.8 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.9 |
3.6 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.9 |
0.9 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.9 |
1.8 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.9 |
0.9 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.9 |
3.6 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.9 |
3.6 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.9 |
0.9 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.9 |
2.7 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.9 |
3.6 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.9 |
0.9 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.9 |
5.4 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.9 |
0.9 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 0.9 |
3.6 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.9 |
2.7 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.9 |
0.9 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
| 0.9 |
1.8 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.9 |
2.7 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.9 |
10.6 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.9 |
4.4 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.9 |
10.6 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.9 |
2.6 |
GO:0070572 |
positive regulation of neuron projection regeneration(GO:0070572) |
| 0.9 |
14.1 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.9 |
0.9 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
| 0.9 |
2.6 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.9 |
4.4 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.9 |
3.5 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.9 |
5.2 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.9 |
0.9 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.9 |
0.9 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.9 |
6.9 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.9 |
2.6 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.9 |
6.0 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.9 |
1.7 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.9 |
0.9 |
GO:1904861 |
excitatory synapse assembly(GO:1904861) |
| 0.9 |
2.6 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.9 |
1.7 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.8 |
8.5 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.8 |
2.5 |
GO:0039017 |
pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) kidney rudiment formation(GO:0072003) kidney field specification(GO:0072004) positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) |
| 0.8 |
16.1 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.8 |
7.6 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.8 |
1.7 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.8 |
3.4 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.8 |
0.8 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.8 |
3.4 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.8 |
0.8 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.8 |
5.8 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.8 |
0.8 |
GO:1904809 |
dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 0.8 |
5.0 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.8 |
1.7 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.8 |
4.1 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.8 |
3.3 |
GO:0042745 |
circadian sleep/wake cycle(GO:0042745) |
| 0.8 |
2.5 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.8 |
1.6 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.8 |
2.5 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.8 |
2.5 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.8 |
0.8 |
GO:0002604 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
| 0.8 |
2.4 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.8 |
5.7 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.8 |
2.4 |
GO:1902310 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.8 |
3.2 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.8 |
1.6 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.8 |
5.7 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.8 |
0.8 |
GO:0045954 |
positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.8 |
0.8 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.8 |
2.4 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.8 |
1.6 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.8 |
0.8 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.8 |
2.4 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.8 |
3.2 |
GO:0014848 |
urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.8 |
2.4 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.8 |
1.6 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.8 |
2.4 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) |
| 0.8 |
3.9 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.8 |
2.4 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.8 |
10.2 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.8 |
3.1 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.8 |
3.9 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.8 |
1.6 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.8 |
1.6 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.8 |
2.3 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.8 |
3.1 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.8 |
3.9 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.8 |
2.3 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.8 |
1.5 |
GO:0046851 |
negative regulation of bone remodeling(GO:0046851) |
| 0.8 |
1.5 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.8 |
2.3 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.8 |
0.8 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.8 |
0.8 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.8 |
3.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.8 |
2.3 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.8 |
1.5 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.8 |
5.4 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.8 |
1.5 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.8 |
0.8 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.8 |
1.5 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.8 |
2.3 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.8 |
6.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.8 |
3.8 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.8 |
3.8 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.8 |
3.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.8 |
2.3 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.8 |
0.8 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.8 |
3.8 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.8 |
5.3 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.8 |
3.0 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.8 |
0.8 |
GO:1904796 |
regulation of core promoter binding(GO:1904796) |
| 0.8 |
1.5 |
GO:0048597 |
post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.8 |
15.0 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.7 |
1.5 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.7 |
1.5 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.7 |
2.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.7 |
1.5 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.7 |
11.1 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.7 |
1.5 |
GO:0051715 |
cytolysis in other organism(GO:0051715) |
| 0.7 |
5.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.7 |
2.9 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.7 |
2.2 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.7 |
2.2 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.7 |
2.9 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.7 |
2.2 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.7 |
8.1 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.7 |
2.9 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.7 |
2.9 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.7 |
2.2 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.7 |
2.2 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.7 |
4.4 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.7 |
1.5 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.7 |
2.9 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.7 |
3.6 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.7 |
2.2 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.7 |
8.7 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.7 |
7.9 |
GO:1905216 |
positive regulation of RNA binding(GO:1905216) |
| 0.7 |
0.7 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.7 |
10.8 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.7 |
6.5 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.7 |
3.6 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.7 |
4.3 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.7 |
2.1 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.7 |
3.6 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.7 |
2.8 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.7 |
5.7 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.7 |
10.6 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.7 |
14.1 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.7 |
2.1 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.7 |
3.5 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.7 |
2.8 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
| 0.7 |
2.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.7 |
0.7 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.7 |
3.5 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.7 |
2.1 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.7 |
0.7 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.7 |
0.7 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.7 |
2.8 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.7 |
2.1 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.7 |
4.2 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.7 |
2.1 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.7 |
2.1 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.7 |
5.5 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.7 |
0.7 |
GO:1902931 |
negative regulation of alcohol biosynthetic process(GO:1902931) |
| 0.7 |
2.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.7 |
2.8 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.7 |
2.1 |
GO:0019400 |
glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
| 0.7 |
0.7 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.7 |
1.4 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.7 |
0.7 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.7 |
2.1 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.7 |
2.1 |
GO:0072717 |
response to actinomycin D(GO:0072716) cellular response to actinomycin D(GO:0072717) |
| 0.7 |
1.4 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.7 |
9.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.7 |
7.5 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.7 |
2.0 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.7 |
3.4 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.7 |
0.7 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.7 |
0.7 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.7 |
3.4 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.7 |
0.7 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) positive regulation of androgen receptor activity(GO:2000825) |
| 0.7 |
2.7 |
GO:0098926 |
postsynaptic signal transduction(GO:0098926) postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.7 |
2.0 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.7 |
6.0 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.7 |
2.0 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.7 |
2.0 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.7 |
2.0 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.7 |
3.3 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.7 |
2.7 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.7 |
4.7 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.7 |
6.7 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.7 |
2.0 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.7 |
2.7 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.7 |
0.7 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.7 |
5.9 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.7 |
1.3 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.7 |
2.0 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.7 |
13.8 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.7 |
2.6 |
GO:0010460 |
positive regulation of heart rate(GO:0010460) |
| 0.7 |
3.3 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.7 |
1.3 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.7 |
0.7 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.7 |
8.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.7 |
2.0 |
GO:1904528 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.7 |
1.3 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.6 |
1.3 |
GO:0070257 |
mucus secretion(GO:0070254) positive regulation of mucus secretion(GO:0070257) |
| 0.6 |
0.6 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.6 |
2.6 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.6 |
3.2 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.6 |
7.1 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.6 |
1.9 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.6 |
13.6 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.6 |
1.3 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.6 |
4.5 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.6 |
25.8 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.6 |
1.3 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.6 |
2.6 |
GO:0046490 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.6 |
6.4 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.6 |
3.2 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.6 |
0.6 |
GO:0033140 |
regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.6 |
3.2 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.6 |
0.6 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.6 |
5.8 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.6 |
1.9 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.6 |
25.5 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.6 |
1.3 |
GO:0032604 |
granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.6 |
0.6 |
GO:0022028 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.6 |
12.6 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.6 |
5.7 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.6 |
8.8 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) |
| 0.6 |
1.9 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.6 |
1.3 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.6 |
3.1 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.6 |
2.5 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.6 |
5.0 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.6 |
1.9 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.6 |
5.0 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.6 |
0.6 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.6 |
1.2 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.6 |
1.2 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.6 |
2.5 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.6 |
0.6 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.6 |
3.7 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.6 |
1.8 |
GO:0034350 |
regulation of glial cell apoptotic process(GO:0034350) |
| 0.6 |
2.4 |
GO:1902340 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.6 |
3.7 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.6 |
1.2 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.6 |
11.0 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.6 |
1.2 |
GO:0098912 |
membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.6 |
0.6 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.6 |
1.8 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.6 |
1.2 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.6 |
3.6 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.6 |
1.8 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.6 |
3.0 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.6 |
3.0 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.6 |
1.8 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.6 |
0.6 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.6 |
1.8 |
GO:0033032 |
regulation of myeloid cell apoptotic process(GO:0033032) |
| 0.6 |
4.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.6 |
0.6 |
GO:0002481 |
antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.6 |
5.4 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.6 |
1.8 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.6 |
4.2 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.6 |
3.0 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.6 |
5.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.6 |
1.2 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.6 |
3.5 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.6 |
8.8 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.6 |
11.7 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.6 |
2.3 |
GO:0032682 |
negative regulation of chemokine production(GO:0032682) |
| 0.6 |
1.8 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.6 |
2.9 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.6 |
2.3 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.6 |
1.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.6 |
1.2 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
| 0.6 |
2.9 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.6 |
2.9 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.6 |
1.2 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.6 |
11.5 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.6 |
2.3 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.6 |
0.6 |
GO:0034398 |
telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.6 |
5.7 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.6 |
0.6 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.6 |
0.6 |
GO:1903305 |
regulation of regulated secretory pathway(GO:1903305) |
| 0.6 |
4.0 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.6 |
28.5 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.6 |
0.6 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) |
| 0.6 |
7.9 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.6 |
0.6 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.6 |
3.9 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.6 |
0.6 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.6 |
2.8 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.6 |
1.7 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.6 |
1.1 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.6 |
1.7 |
GO:2000016 |
negative regulation of determination of dorsal identity(GO:2000016) |
| 0.6 |
6.7 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.6 |
3.3 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.6 |
0.6 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.6 |
1.7 |
GO:0090208 |
positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.6 |
1.1 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.6 |
1.1 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.6 |
1.1 |
GO:0040010 |
positive regulation of growth rate(GO:0040010) |
| 0.6 |
2.2 |
GO:1903431 |
positive regulation of cell maturation(GO:1903431) |
| 0.6 |
1.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.6 |
0.6 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) |
| 0.6 |
1.1 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.6 |
1.7 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.6 |
8.3 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.6 |
1.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.6 |
1.1 |
GO:0071380 |
cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.5 |
2.7 |
GO:0001916 |
positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.5 |
6.6 |
GO:0086011 |
membrane repolarization during action potential(GO:0086011) |
| 0.5 |
6.5 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.5 |
2.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.5 |
0.5 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.5 |
0.5 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.5 |
3.2 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.5 |
1.6 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.5 |
1.6 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.5 |
2.1 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.5 |
2.7 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.5 |
5.9 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.5 |
1.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.5 |
5.9 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.5 |
1.6 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.5 |
2.1 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.5 |
0.5 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.5 |
1.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.5 |
0.5 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.5 |
1.6 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.5 |
1.1 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.5 |
4.2 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.5 |
0.5 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.5 |
1.6 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.5 |
0.5 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.5 |
3.7 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.5 |
2.1 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.5 |
1.0 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.5 |
8.4 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.5 |
2.1 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.5 |
2.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.5 |
4.2 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.5 |
6.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.5 |
22.3 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.5 |
31.5 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.5 |
1.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.5 |
3.6 |
GO:0030815 |
negative regulation of cAMP metabolic process(GO:0030815) |
| 0.5 |
2.6 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.5 |
4.1 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.5 |
3.6 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.5 |
0.5 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.5 |
2.0 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.5 |
2.0 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.5 |
11.7 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.5 |
1.0 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.5 |
0.5 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.5 |
2.5 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.5 |
13.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.5 |
17.0 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.5 |
1.0 |
GO:0061357 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.5 |
0.5 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.5 |
3.5 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.5 |
1.5 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.5 |
2.0 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.5 |
0.5 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.5 |
4.9 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.5 |
15.3 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.5 |
0.5 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.5 |
1.5 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.5 |
0.5 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.5 |
1.0 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.5 |
2.9 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.5 |
1.5 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) |
| 0.5 |
1.5 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.5 |
3.4 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.5 |
1.9 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.5 |
1.0 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.5 |
3.9 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.5 |
0.5 |
GO:1990000 |
amyloid fibril formation(GO:1990000) |
| 0.5 |
1.4 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.5 |
3.4 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.5 |
2.4 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.5 |
0.5 |
GO:1903421 |
regulation of synaptic vesicle recycling(GO:1903421) |
| 0.5 |
0.5 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) olefin metabolic process(GO:1900673) |
| 0.5 |
2.4 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.5 |
1.4 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.5 |
1.0 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.5 |
4.7 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.5 |
0.5 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.5 |
0.9 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.5 |
1.9 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.5 |
1.4 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.5 |
0.5 |
GO:0007007 |
inner mitochondrial membrane organization(GO:0007007) |
| 0.5 |
0.5 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.5 |
0.5 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.5 |
3.2 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.5 |
0.9 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.5 |
0.5 |
GO:0002677 |
negative regulation of chronic inflammatory response(GO:0002677) |
| 0.5 |
1.4 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.5 |
0.5 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.5 |
0.5 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.5 |
0.9 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.5 |
1.8 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.5 |
9.6 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.5 |
3.2 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.5 |
2.7 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.5 |
4.5 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.5 |
0.9 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.5 |
0.5 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.5 |
1.4 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.4 |
0.4 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.4 |
0.4 |
GO:0019389 |
glucuronoside metabolic process(GO:0019389) |
| 0.4 |
1.3 |
GO:1902175 |
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
| 0.4 |
1.8 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.4 |
0.4 |
GO:1990182 |
exosomal secretion(GO:1990182) |
| 0.4 |
1.3 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.4 |
5.3 |
GO:0000423 |
macromitophagy(GO:0000423) |
| 0.4 |
0.4 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.4 |
0.9 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.4 |
1.3 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.4 |
2.6 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.4 |
0.4 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) |
| 0.4 |
1.3 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.4 |
0.4 |
GO:0035937 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.4 |
2.2 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.4 |
6.5 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.4 |
2.6 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.4 |
2.6 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.4 |
1.3 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.4 |
9.0 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.4 |
0.9 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.4 |
3.0 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.4 |
1.3 |
GO:1903977 |
positive regulation of Schwann cell migration(GO:1900149) positive regulation of glial cell migration(GO:1903977) |
| 0.4 |
2.5 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.4 |
0.4 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.4 |
0.4 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.4 |
1.7 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.4 |
7.6 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.4 |
1.7 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.4 |
0.4 |
GO:0051904 |
pigment granule transport(GO:0051904) |
| 0.4 |
18.0 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.4 |
1.3 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.4 |
1.3 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.4 |
0.4 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.4 |
0.8 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.4 |
8.4 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.4 |
1.7 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.4 |
4.2 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.4 |
3.7 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.4 |
0.4 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.4 |
0.8 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.4 |
0.4 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.4 |
2.0 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.4 |
2.4 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.4 |
0.8 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.4 |
1.2 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 |
0.8 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.4 |
1.6 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
| 0.4 |
7.2 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.4 |
0.8 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.4 |
10.0 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.4 |
0.8 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.4 |
1.2 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.4 |
3.2 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.4 |
1.2 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.4 |
0.8 |
GO:0099550 |
trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 0.4 |
8.7 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.4 |
0.4 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.4 |
5.9 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.4 |
0.8 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.4 |
1.2 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 |
0.8 |
GO:0032070 |
regulation of deoxyribonuclease activity(GO:0032070) |
| 0.4 |
1.9 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.4 |
2.7 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.4 |
0.8 |
GO:2000108 |
positive regulation of leukocyte apoptotic process(GO:2000108) |
| 0.4 |
7.7 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.4 |
1.9 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.4 |
1.2 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.4 |
1.9 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.4 |
1.2 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.4 |
3.1 |
GO:0044803 |
multi-organism membrane organization(GO:0044803) |
| 0.4 |
3.1 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.4 |
0.4 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.4 |
1.5 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.4 |
1.5 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.4 |
1.9 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.4 |
0.8 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.4 |
1.9 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.4 |
1.5 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.4 |
0.4 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.4 |
3.4 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.4 |
3.0 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.4 |
1.5 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.4 |
2.2 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.4 |
3.4 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.4 |
1.1 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.4 |
3.7 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.4 |
0.4 |
GO:0044110 |
growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
| 0.4 |
3.3 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.4 |
2.6 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
| 0.4 |
1.1 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.4 |
1.1 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.4 |
1.5 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.4 |
9.2 |
GO:0006779 |
porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.4 |
1.5 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.4 |
3.3 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.4 |
1.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.4 |
0.4 |
GO:0097154 |
GABAergic neuron differentiation(GO:0097154) |
| 0.4 |
0.4 |
GO:0042637 |
catagen(GO:0042637) |
| 0.4 |
1.1 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.4 |
1.4 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.4 |
1.1 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.4 |
1.4 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.4 |
0.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.4 |
2.5 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.4 |
1.1 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.4 |
1.1 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.4 |
1.8 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.4 |
0.4 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.4 |
8.2 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.4 |
1.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.4 |
1.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.4 |
3.9 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.4 |
0.7 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.4 |
1.8 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.4 |
1.8 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.4 |
6.0 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.4 |
0.4 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.4 |
1.4 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.4 |
0.4 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.4 |
3.9 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.3 |
4.9 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.3 |
1.0 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.3 |
0.3 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.3 |
0.7 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.3 |
0.3 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.3 |
5.9 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.3 |
1.4 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.3 |
2.4 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 |
1.4 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.3 |
1.7 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.3 |
20.4 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.3 |
1.0 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.3 |
1.0 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.3 |
0.3 |
GO:0070343 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.3 |
0.7 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.3 |
0.3 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.3 |
1.0 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.3 |
1.0 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.3 |
0.3 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.3 |
2.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.3 |
3.0 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.3 |
3.0 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.3 |
6.0 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.3 |
0.3 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.3 |
1.3 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.3 |
1.0 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
1.3 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.3 |
0.7 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.3 |
1.0 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.3 |
1.0 |
GO:0034123 |
positive regulation of toll-like receptor signaling pathway(GO:0034123) |
| 0.3 |
5.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.3 |
0.3 |
GO:0019042 |
viral latency(GO:0019042) |
| 0.3 |
0.3 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.3 |
0.7 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.3 |
0.7 |
GO:2001184 |
regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
0.3 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.3 |
0.3 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 |
0.3 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.3 |
1.0 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 |
1.0 |
GO:1904207 |
chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.3 |
1.0 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.3 |
7.1 |
GO:0043039 |
tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
| 0.3 |
1.9 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.3 |
0.6 |
GO:0044241 |
lipid digestion(GO:0044241) |
| 0.3 |
0.3 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.3 |
0.6 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.3 |
0.3 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.3 |
0.3 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.3 |
0.3 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.3 |
1.6 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.3 |
5.0 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.3 |
0.6 |
GO:0007006 |
mitochondrial membrane organization(GO:0007006) |
| 0.3 |
0.6 |
GO:0051350 |
negative regulation of lyase activity(GO:0051350) |
| 0.3 |
2.2 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.3 |
0.3 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.3 |
0.6 |
GO:0032692 |
negative regulation of interleukin-1 production(GO:0032692) |
| 0.3 |
1.2 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.3 |
1.5 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 |
1.2 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.3 |
0.9 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.3 |
2.8 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.3 |
0.6 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.3 |
19.5 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.3 |
0.3 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 |
2.1 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.3 |
2.7 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.3 |
1.5 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.3 |
2.4 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.3 |
0.3 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.3 |
0.9 |
GO:0046112 |
nucleobase biosynthetic process(GO:0046112) |
| 0.3 |
1.2 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.3 |
0.6 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.3 |
3.8 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.3 |
1.2 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.3 |
1.2 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.3 |
1.2 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 |
4.9 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.3 |
0.9 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.3 |
0.6 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.3 |
0.9 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.3 |
0.6 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.3 |
4.0 |
GO:0015992 |
proton transport(GO:0015992) |
| 0.3 |
2.6 |
GO:0032715 |
negative regulation of interleukin-6 production(GO:0032715) |
| 0.3 |
2.0 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.3 |
0.9 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.3 |
0.6 |
GO:0018377 |
N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.3 |
1.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.3 |
0.6 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.3 |
0.6 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.3 |
1.1 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.3 |
2.3 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.3 |
0.6 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.3 |
0.6 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) |
| 0.3 |
2.0 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.3 |
1.9 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.3 |
0.3 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.3 |
0.6 |
GO:0048087 |
positive regulation of developmental pigmentation(GO:0048087) |
| 0.3 |
0.8 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 |
0.3 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.3 |
1.4 |
GO:0036376 |
sodium ion export from cell(GO:0036376) |
| 0.3 |
15.5 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.3 |
0.8 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.3 |
0.5 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.3 |
2.4 |
GO:0002093 |
auditory receptor cell morphogenesis(GO:0002093) |
| 0.3 |
1.6 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.3 |
1.3 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.3 |
0.8 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
0.3 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.3 |
0.3 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
0.8 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.3 |
5.8 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.3 |
3.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.3 |
0.3 |
GO:0010575 |
positive regulation of vascular endothelial growth factor production(GO:0010575) |
| 0.3 |
0.3 |
GO:0008209 |
androgen metabolic process(GO:0008209) |
| 0.3 |
2.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.3 |
1.3 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.3 |
0.3 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) |
| 0.3 |
0.3 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) |
| 0.3 |
1.0 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.3 |
1.0 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.3 |
0.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 |
0.5 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.3 |
1.0 |
GO:0045852 |
lysosomal lumen pH elevation(GO:0035752) pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.3 |
0.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 |
1.8 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.3 |
0.3 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.2 |
1.2 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.2 |
1.2 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.2 |
5.4 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.2 |
2.4 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.2 |
1.0 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.2 |
1.7 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.2 |
0.2 |
GO:1902548 |
negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.2 |
0.7 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 |
2.7 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 |
0.5 |
GO:0043516 |
regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
| 0.2 |
0.5 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.2 |
0.7 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.2 |
0.5 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.2 |
1.0 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 |
1.9 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
0.2 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.2 |
0.2 |
GO:0046113 |
nucleobase catabolic process(GO:0046113) |
| 0.2 |
0.9 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
0.5 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.2 |
4.0 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.2 |
0.5 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.2 |
0.5 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.2 |
0.5 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 |
1.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 |
0.2 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.2 |
0.2 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.2 |
0.2 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
3.2 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.2 |
0.5 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.2 |
0.7 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.2 |
0.9 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 |
0.5 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.2 |
0.4 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 |
3.1 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
0.4 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.2 |
0.7 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.2 |
2.0 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.2 |
1.3 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.2 |
0.2 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.2 |
1.3 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.2 |
0.4 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.2 |
0.4 |
GO:0035878 |
nail development(GO:0035878) |
| 0.2 |
1.3 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.2 |
0.9 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.2 |
0.6 |
GO:0010873 |
positive regulation of cholesterol esterification(GO:0010873) |
| 0.2 |
0.4 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 |
0.2 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 |
0.4 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
0.6 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) |
| 0.2 |
0.9 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 |
1.3 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.2 |
0.4 |
GO:0032094 |
response to food(GO:0032094) |
| 0.2 |
0.4 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.2 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.2 |
1.3 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.2 |
1.3 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.2 |
0.4 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.2 |
0.8 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.2 |
1.2 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.2 |
1.0 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.2 |
5.2 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.2 |
0.2 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.2 |
2.7 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 |
0.8 |
GO:0018201 |
peptidyl-glycine modification(GO:0018201) |
| 0.2 |
1.6 |
GO:0032438 |
melanosome organization(GO:0032438) |
| 0.2 |
0.4 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.2 |
1.8 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
6.1 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.2 |
1.2 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.2 |
7.8 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.2 |
0.8 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 |
0.4 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.2 |
0.6 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.2 |
1.6 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.2 |
0.4 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.2 |
1.6 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.2 |
1.6 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.2 |
1.0 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.2 |
0.4 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 |
1.8 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.2 |
0.2 |
GO:1900120 |
regulation of receptor binding(GO:1900120) |
| 0.2 |
2.0 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.2 |
0.4 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.2 |
0.2 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 |
9.9 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.2 |
0.2 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.2 |
0.4 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.2 |
0.6 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.2 |
3.2 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.2 |
1.3 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.2 |
0.2 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.2 |
1.1 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 |
0.2 |
GO:0002176 |
male germ cell proliferation(GO:0002176) |
| 0.2 |
0.9 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.2 |
0.9 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.2 |
0.4 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.2 |
3.1 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.2 |
1.5 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 |
0.4 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.2 |
0.2 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.2 |
1.5 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 |
0.5 |
GO:1902396 |
positive regulation of pinocytosis(GO:0048549) protein localization to bicellular tight junction(GO:1902396) |
| 0.2 |
0.4 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.2 |
0.2 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.2 |
1.4 |
GO:0098781 |
ncRNA transcription(GO:0098781) |
| 0.2 |
0.2 |
GO:0032610 |
interleukin-1 alpha production(GO:0032610) |
| 0.2 |
0.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
0.7 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.2 |
0.7 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.2 |
0.5 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.2 |
1.6 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.2 |
0.2 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.2 |
0.7 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.2 |
2.1 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 |
0.3 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.2 |
1.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 |
3.9 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.2 |
0.7 |
GO:0034312 |
diol biosynthetic process(GO:0034312) |
| 0.2 |
3.2 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.2 |
0.3 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.2 |
1.2 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.2 |
0.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
3.7 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 |
0.5 |
GO:0045606 |
positive regulation of epidermal cell differentiation(GO:0045606) positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.2 |
0.8 |
GO:0016048 |
detection of temperature stimulus(GO:0016048) |
| 0.2 |
0.2 |
GO:0002666 |
positive regulation of T cell tolerance induction(GO:0002666) positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 |
1.1 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.2 |
0.8 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.2 |
0.3 |
GO:2000157 |
negative regulation of protein deubiquitination(GO:0090086) regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 |
0.3 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.2 |
1.3 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
0.5 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.2 |
7.0 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.2 |
1.1 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.2 |
0.6 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.2 |
0.3 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
0.6 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.2 |
0.9 |
GO:1903961 |
positive regulation of anion transmembrane transport(GO:1903961) |
| 0.2 |
0.2 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.2 |
0.3 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.2 |
0.8 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.2 |
0.3 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
0.4 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.1 |
0.3 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
1.3 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
0.9 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 |
3.1 |
GO:0072655 |
establishment of protein localization to mitochondrion(GO:0072655) |
| 0.1 |
2.2 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 |
0.7 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.1 |
0.3 |
GO:2000407 |
T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
| 0.1 |
0.3 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) |
| 0.1 |
0.6 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.9 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
0.4 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.1 |
0.7 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
1.3 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.8 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.1 |
1.1 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.1 |
1.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
2.2 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.1 |
0.5 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.1 |
2.0 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.1 |
0.3 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
1.7 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.3 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.3 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.1 |
2.2 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.1 |
1.8 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.1 |
2.6 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.3 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.1 |
0.5 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 |
0.6 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.2 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 |
0.5 |
GO:1903028 |
asymmetric Golgi ribbon formation(GO:0090164) regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.1 |
1.2 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.1 |
0.5 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.1 |
0.5 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 |
0.5 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
1.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.1 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
0.2 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 |
0.5 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.1 |
0.1 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
1.3 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.5 |
GO:0070542 |
response to fatty acid(GO:0070542) |
| 0.1 |
0.9 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.1 |
3.3 |
GO:1901379 |
regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.1 |
0.7 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.2 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 |
0.2 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 |
0.3 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
1.9 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 |
0.3 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.1 |
0.3 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.1 |
0.8 |
GO:1901985 |
positive regulation of protein acetylation(GO:1901985) |
| 0.1 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
0.3 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
0.9 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.1 |
1.3 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
1.2 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.1 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) |
| 0.1 |
0.9 |
GO:0046838 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) |
| 0.1 |
0.5 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
3.4 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.3 |
GO:0006001 |
fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.1 |
1.9 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
0.2 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 |
0.3 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 |
0.2 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.1 |
5.0 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.1 |
0.8 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
1.6 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.1 |
0.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.3 |
GO:0090063 |
regulation of microtubule nucleation(GO:0010968) positive regulation of microtubule nucleation(GO:0090063) |
| 0.1 |
0.2 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.1 |
5.1 |
GO:0035308 |
negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 |
1.5 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.2 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
1.4 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.2 |
GO:0048209 |
regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.1 |
0.2 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.5 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 |
0.3 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.1 |
1.2 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.1 |
1.4 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.1 |
0.3 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.1 |
0.2 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.1 |
0.2 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.1 |
1.2 |
GO:0048489 |
synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
| 0.1 |
2.7 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.2 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.1 |
0.2 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.1 |
0.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.1 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.1 |
0.1 |
GO:0043278 |
response to morphine(GO:0043278) |
| 0.1 |
0.6 |
GO:0043173 |
nucleotide salvage(GO:0043173) |
| 0.1 |
0.1 |
GO:0098928 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.1 |
0.2 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.1 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.1 |
0.1 |
GO:0034114 |
regulation of heterotypic cell-cell adhesion(GO:0034114) |
| 0.1 |
0.5 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.1 |
2.0 |
GO:0031929 |
TOR signaling(GO:0031929) |
| 0.1 |
0.9 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.1 |
0.1 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.1 |
0.4 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.2 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
0.2 |
GO:0009148 |
pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
| 0.1 |
0.1 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.1 |
0.3 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.1 |
0.1 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) |
| 0.1 |
1.6 |
GO:0006839 |
mitochondrial transport(GO:0006839) |
| 0.1 |
0.4 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
0.6 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 0.1 |
0.6 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.1 |
0.5 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
0.2 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.5 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.9 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
0.5 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.2 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.1 |
GO:1904851 |
positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.0 |
0.5 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.2 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.2 |
GO:0016137 |
glycoside metabolic process(GO:0016137) |
| 0.0 |
0.2 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.4 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.0 |
0.0 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.0 |
0.4 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.3 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.1 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.0 |
0.0 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.0 |
0.0 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.1 |
GO:0048631 |
skeletal muscle tissue growth(GO:0048630) regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.3 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.0 |
GO:0090181 |
regulation of cholesterol metabolic process(GO:0090181) |
| 0.0 |
0.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.1 |
GO:0060690 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) |
| 0.0 |
0.1 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
1.6 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
1.0 |
GO:0071804 |
cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.0 |
0.4 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.0 |
0.1 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.0 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 |
0.1 |
GO:0090002 |
establishment of protein localization to plasma membrane(GO:0090002) |
| 0.0 |
1.1 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.1 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.0 |
0.1 |
GO:0019585 |
uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
| 0.0 |
0.1 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.0 |
0.0 |
GO:1904872 |
regulation of telomerase RNA localization to Cajal body(GO:1904872) |
| 0.0 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.1 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.0 |
0.2 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.0 |
0.1 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.0 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.1 |
GO:1900015 |
regulation of cytokine production involved in inflammatory response(GO:1900015) |
| 0.0 |
0.1 |
GO:0019935 |
cyclic-nucleotide-mediated signaling(GO:0019935) |
| 0.0 |
0.1 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.0 |
0.2 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.0 |
0.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.1 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.0 |
0.0 |
GO:0002946 |
tRNA C5-cytosine methylation(GO:0002946) |
| 0.0 |
0.1 |
GO:0045123 |
cellular extravasation(GO:0045123) |
| 0.0 |
0.1 |
GO:0035967 |
cellular response to topologically incorrect protein(GO:0035967) |
| 0.0 |
0.1 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.1 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.0 |
0.1 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.0 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.0 |
0.0 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.0 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
